8-K//Current report
Clarus Therapeutics Holdings, Inc. 8-K
Accession 0001213900-22-056275
CIK 0001817944operating
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 5:02 PM ET
Size
256.1 KB
Accession
0001213900-22-056275
Documents
- 8-Kea165839-8k_clarusthera.htmPrimary
CURRENT REPORT
- EX-16.1ea165839ex16-1_clarusthera.htm
LETTER FROM RSM US LLP, DATED SEPTEMBER 15, 2022
- EX-101.SCHcrxt-20220915.xsd
XBRL SCHEMA FILE
- EX-101.DEFcrxt-20220915_def.xml
XBRL DEFINITION FILE
- EX-101.LABcrxt-20220915_lab.xml
XBRL LABEL FILE
- EX-101.PREcrxt-20220915_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLea165839-8k_clarusthera_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-22-056275-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
Clarus Therapeutics Holdings, Inc.
CIK 0001817944
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001817944
Filing Metadata
- Form type
- 8-K
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 5:02 PM ET
- Size
- 256.1 KB